DABITRAN 150MG 30TABLET

DABITRAN 150MG CAPSULES: Advanced Anticoagulation for Cardiovascular Health

Dabigatran (marketed as Pradaxa) 150mg capsules are a leading oral anticoagulant designed to provide crucial protection against blood clot formation.

This prescription medication effectively reduces the risk of stroke and systemic embolism in patients diagnosed with non-valvular atrial fibrillation (NVAF).

Furthermore, it is indicated for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE), offering comprehensive cardiovascular protection.

Manufactured by Boehringer Ingelheim, DABITRAN 150mg represents a vital therapeutic option in anticoagulation management.

Each capsule contains 150mg of dabigatran etexilate, formulated for optimal absorption and efficacy.

Benefits of Use:

• Significantly reduces the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
• Effective for the treatment of acute deep vein thrombosis (DVT) and pulmonary embolism (PE).
• Prevents recurrence of DVT and PE, enhancing long-term patient outcomes.
• Offers an oral alternative to traditional anticoagulants, improving patient convenience and adherence.
• Rapid onset of action compared to some other anticoagulants.

How to Use:

1. Always take DABITRAN 150mg capsules exactly as prescribed by your healthcare provider.
2. Swallow the capsule whole with a glass of water, with or without food.
3. Do not open, chew, or crush the capsules, as this may alter drug absorption and efficacy.
4. If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose. Do not take two doses at once to make up for a missed dose.
5. For specific dosing schedules related to stroke prevention in NVAF or DVT/PE treatment, consult your physician.

Caution & Warnings:

• Bleeding Risk: DABITRAN increases the risk of bleeding, which can be serious and potentially fatal. Inform your doctor immediately if you experience unusual bruising, prolonged bleeding, or blood in urine/stools.
• Spinal/Epidural Hematoma: Patients undergoing spinal or epidural puncture/anesthesia are at risk of developing spinal or epidural hematoma, which can result in long-term or permanent paralysis.
• Kidney Function: Dose adjustments may be necessary for patients with impaired kidney function. Regular monitoring is crucial.
• Surgery/Procedures: Inform your doctor or dentist you are taking DABITRAN before any surgery or dental procedures, as it may need to be temporarily stopped.
• Pregnancy/Breastfeeding: Not recommended during pregnancy or breastfeeding unless clearly necessary and advised by a physician.
• Drug Interactions: Inform your doctor about all other medications you are taking, including over-the-counter drugs and herbal supplements, as serious interactions can occur.
• Storage: Store at room temperature, protected from moisture. Keep the bottle tightly closed.

Ingredients:

• Active Ingredient: Dabigatran Etexilate (150mg)
• Excipients: May include tartaric acid, acacia, hypromellose, dimethicone, talc, carrageenan, potassium chloride, titanium dioxide, indigo carmine (E132) and shellac, depending on the specific formulation. Refer to the package leaflet for the full list.

Product Details:

• Brand: Pradaxa (DABITRAN)
• Manufacturer: Boehringer Ingelheim
• Dosage Form: Capsule
• Strength: 150mg
• Package Size: 30 Capsules
• Drug Type: Prescription Only Medicine (POM)
• Administration Route: Oral